Neurocrine Biosciences
NBIX
#1304
Rank
A$25.56 B
Marketcap
A$252.58
Share price
2.31%
Change (1 day)
10.02%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company